Seven or eight years ago, I paid a small fee for a downloadable PDF of breathing exercises from Wim Hof, who was in process of sharing what he had learned in his journey that involved various breathing and other exercises. Off I went, hyperventilating away, and marveling at how long I could hold my breath,…
I was listening to a podcast this week where Jim Collins raised an issue that comes up time and again. “Can a founder really transition to being a company builder?” While we tend to associate Collins with iconic companies, many of the companies he works with remain led by their founders. A rough estimation of…
I want to wish all of you the best this holiday season. I’ve been considering how we, as businesses and individuals, mark the holidays this year. I think it is one where the variety of experiences needs to be recognized and considered especially by those of us that have had the good fortune to see…
During much of 2020, there have been calls to “onshore,” or “reshore” API (Active Pharmaceutical Ingredient) manufacturing to the United States. Supply chain gaps in capacity, both local and global, became more apparent, something that most industry experts and the FDA knew existed on some level. It was a normal fear and security response to…